Annual report pursuant to Section 13 and 15(d)

Consolidated Statements of Cash Flows

v3.24.0.1
Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
 12 Months Ended
Dec. 30, 2023
Dec. 31, 2022
Jan. 01, 2022
Cash flows from operating activities      
Net earnings $ 63,788 $ 69,350 $ 116,505
Adjustments to reconcile net earnings to net cash provided by (used in) operating activities      
Depreciation and amortization 12,702 13,393 13,036
Right-of-use asset amortization 7,693 8,017 9,157
(Gain) loss on sale of property and equipment 10 141 61
Equity-based compensation expense 14,595 13,331 14,298
Deferred income taxes (2,749) (7,183) (2,970)
Inventory write-down 2,601 6,082 4,200
Changes in operating assets and liabilities, net of acquisitions:      
Inventories 2,353 15,797 (14,701)
Prepaid expenses and other assets 110 (3,304) (2,331)
Accounts payable (428) (2,656) (4,572)
Other liabilities (30,034) (9,066) (11,456)
Net cash provided by (used in) operating activities 70,641 103,902 121,227
Cash flows from investing activities      
Receipts on notes receivable 0 0 116
Proceeds from the settlement of net investment hedges 3,775 4,555 0
Payments for net investment hedge (1,271) 0 (1,555)
Payments to acquire businesses 0 (6,532) 0
Proceeds from sale of property and equipment 15 7 15
Purchases of property and equipment (14,494) (10,400) (12,763)
Net cash provided by (used in) investing activities (11,975) (12,370) (14,187)
Cash flows from financing activities      
Repurchase of common stock (11,599) (25,382) (177,837)
Borrowings on line of credit 1,542 11,000 0
Payments on line of credit (750) (11,000) 0
Payments related to tax withholding for net-share settled equity awards (3,092) (4,706) (3,575)
Payments for contingent consideration (338) 0 0
Net cash provided by (used in) financing activities (14,237) (30,088) (181,412)
Effect of exchange rate changes on cash, cash equivalents, and restricted cash (2,503) (13,777) 2,088
Net increase (decrease) in cash, cash equivalents, and restricted cash 41,926 47,667 (72,284)
Cash, cash equivalents, and restricted cash at beginning of period 291,320 243,653 315,937
Cash, cash equivalents, and restricted cash at end of period 333,246 291,320 243,653
Reconciliation of cash, cash equivalents, and restricted cash to the consolidated balance sheets      
Cash and cash equivalents 330,420 288,420 239,832
Restricted cash included in other assets 2,826 2,900 3,821
Total cash, cash equivalents, and restricted cash 333,246 291,320 243,653
Cash paid during the period for:      
Interest 68 49 10
Income taxes 44,247 45,863 59,524
Cash received during the period for:      
Income tax refund 1,922 113 191
Non-cash investing and financing activities:      
Right-of-use assets obtained in exchange for lease obligations 5,699 5,641 5,322
Accrued purchases of property and equipment 117 679 383
Contingent consideration given to acquire businesses 0 886 0
Accrued excise tax for repurchase of common stock $ 54 $ 0 $ 0